英维克(002837.SZ)实控人齐勇质押571万股
格隆汇12月16日丨英维克(002837.SZ)公布,公司于近日接到实际控制人齐勇的通知,获悉齐勇所持有公司的部分股份被质押,质押571万股,占其所持股份比例42.92%,占公司总股本比例2.66%。
截至公告披露日,齐勇直接持有公司股份1330.47万股,占公司总股本的6.19%,累计质押的股份总数为571万股,占其所持股份的42.92%,占公司总股本的2.66%。公司实际控制人齐勇与公司控股股东深圳市英维克投资有限公司(“英维克投资”)为一致行动人,合计持有公司股份7049.68万股,合计质押3952.18万股,占合计持有公司股份总数的56.06%,占公司总股本的18.40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.